Results 71 to 80 of about 1,383,644 (223)

Impact of Physical Exercise on Menopause Symptoms and Health-related quality of life - a literature review

open access: yesJournal of Education, Health and Sport
Menopause, which usually occurs between the ages of 45 and 56, is a natural biological condition that signifies the end of a woman's menstrual cycles.
Agnieszka Wąsowicz   +9 more
doaj   +1 more source

Comparative Efficacy of Elinzanetant Versus Other Non‐Hormonal Pharmaceutical Therapies for the Treatment of Moderate‐to‐Severe Vasomotor Symptoms Associated With Menopause: A Network Meta‐Analysis

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Elinzanetant, a novel, dual neurokinin‐targeted therapy, has been approved in various geographies for the treatment of moderate‐to‐severe vasomotor symptoms (VMS) associated with menopause. Objective To compare the efficacy of elinzanetant with non‐hormonal pharmaceutical treatments (nHT) in alleviating VMS.
Piotr Wojciechowski   +8 more
wiley   +1 more source

Potential role of gabapentin and extended- release gabapentin in the management of menopausal hot flashes

open access: yesInternational Journal of General Medicine, 2013
Manisha Yadav, Judith Volkar Center for Specialized Women’s Health, Cleveland Clinic Foundation, Cleveland, Ohio, USA Abstract: About 80% of postmenopausal women experience vasomotor symptoms, such as hot flashes and night sweats – symptoms ...
Yadav M, Volkar J
doaj  

Periodic Limb Movements are Associated with Vasomotor Symptoms

open access: yes, 2014
Study objectives: Periodic limb movements (PLMs) are characterized by involuntary movements of the lower extremity during sleep. The etiology of PLM has been suggested to involve the dopaminergic system which, in turn, can be modulated by estrogen. It is
Wesström, Jan,   +3 more
core   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas   +3 more
wiley   +1 more source

COMPARISON OF VASOMOTOR SYMPTOMS IN POSTMENOPAUSAL WOMEN WITH DIFFERENT SOCIO-ECONOMIC STATUS

open access: yesGomal Journal of Medical Sciences, 2014
Background: Menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity. The diagnosis of menopause can usually be ascertained from vasomotor symptoms and prolonged episode of amenorrhea. Many factors including
Shandana Bawar   +3 more
doaj  

Variation in menopausal vasomotor symptoms outcomes in clinical trials: A systematic review [PDF]

open access: yes, 2019
Background There is substantial variation in how menopausal vasomotor symptoms are reported and measured among intervention studies. This has prevented meaningful comparisons between treatments and limited data synthesis.
Iliodromiti, S.   +20 more
core   +1 more source

Impact of barometric pressure on blood pressure during dialysis: Introducing intradialytic time‐averaged cumulative systolic blood pressure (TACsBP‐inD) as a new metric

open access: yesTherapeutic Apheresis and Dialysis, Volume 29, Issue 3, Page 525-534, June 2025.
Abstract Background Blood pressure is a crucial risk factor for hemodialysis patients, but the specific impact of weather factors, particularly barometric pressure, on blood pressure remains unclear. This study aims to examine the relationship between barometric pressure and blood pressure in hemodialysis patients. Methods We conducted a single‐center,
Kosaku Iwatsubo   +2 more
wiley   +1 more source

Why are views on the management of patients with vasomotor rhinitis changing?

open access: yesInfusion & Chemotherapy
BACKGROUND. Vasomotor rhinitis represents a significant global health burden, with prevalence rates ranging from 5 to 25 %. It is a subtype of non-allergic rhinitis, a heterogeneous group of disorders characterized by rhinitis symptoms not caused by ...
S.V. Zaikov   +4 more
doaj   +1 more source

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom

open access: yes, 2013
Marco daCosta DiBonaventura,1 Arthi Chandran,2 Ming-Ann Hsu,3 Andrew Bushmakin41Health Outcomes Practice, Kantar Health, New York, NY, USA; 2Global Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, USA; 3Global Health Economics and ...
Chandran A   +3 more
core  

Home - About - Disclaimer - Privacy